Consequently, increased GLUT1 expression has been observed in various cancer types, including lung cancer, breast cancer, and bladder cancer [69,70,71,72], indicating GLUT1′s significance as a prognostic indicator for tumorigenesis and as a promising target for the discovery of novel anticancer drugs. This evidence concerns the gene SLC2A1 and urinary bladder carcinoma.